Research Article
The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China
Table 3
Comparison of costs (USD) on detecting RIF-resistant childhood TB patients from different specimen types.
| ā | ā | Specimen types | CSF | GLA | BALF | Sputum | Average |
| Gold standard 1 = solid culture | Per positive case | Xpert | 276.00 | 100.23 | 125.30 | 111.28 | 131.86 | Per RIF- case | Xpert | 1932.02 | 1202.78 | 1628.96 | 890.25 | 1371.36 |
| Gold standard 2 = clinical diagnosis | Per positive case | Solid culture | 72.88 | 36.30 | 40.96 | 37.31 | 43.84 | Xpert | 120.75 | 37.01 | 44.03 | 42.39 | 49.33 | Per RIF- case | Solid culture | 992.44 | 783.28 | 1009.96 | 573.11 | 828.41 | Xpert | 966.01 | 601.39 | 814.48 | 890.25 | 761.86 |
|
|
RIF-R: rifampicin-resistant.
|